Evidence map›Paper›PMID 39145297›Full record

ArticleFrontiers in neuroscience2024

Dan-Dan Ruan, Jing Zou, Li-Sheng Liao, Ming-Dong Ji, Ruo-Li Wang, Jian-Hui Zhang, Li Zhang, Mei-Zhu Gao, Qian Chen, Hong-Ping Yu and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dan-Dan Ruan *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Jing Zou *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Li-Sheng Liao *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Ming-Dong Ji *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Ruo-Li WangShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Jian-Hui ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Li ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Mei-Zhu GaoShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Qian ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Hong-Ping YuShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Wen WeiDepartment of Rehabilitation Medicine, Ganzhou Municipal Hospital, Ganzhou, China.
Yun-Fei LiShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Hong LiShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Fan LinShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Jie-Wei LuoShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Xin-Fu LinShengli Clinical Medical College of Fujian Medical University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We previously reported that ATP1A3 c.823G>C (p.Ala275Pro) mutant causes varying phenotypes of alternative hemiplegia of childhood and rapid-onset dystonia-parkinsonism in the same family. This study aims to investigate the function of Methods: ATP1A3 wild-type and mutant Hela cell lines were constructed, and ATP1A3 mRNA expression, Results: Cells carrying the p.Ala275Pro mutation exhibited lower levels of Conclusion: This study reveals that the p.Ala275Pro mutant decreases

Indexed as

alternating hemiplegia of childhoodATP1A3Na+/K+-ATPaserapid-onset dystonia-parkinsonismzebrafish

Identifiers

PMID39145297
PMCPMC11322359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.